Home › Cancro alla prostata › Florida › Orlando
Studi clinici su Cancro alla prostata a Orlando, FL
17 studi su Cancro alla prostata cercano partecipanti presso sedi a Orlando e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
In reclutamentoFase 1/2
- Advent Health, Orlando
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 2
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · a 16 mi di distanza
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
In reclutamentoFase 2/3
- AdventHealth, Orlando
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
In reclutamentoFase 3
- AdventHealth, Orlando
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
In reclutamentoFase 2
- Orlando VA Medical Center, Orlando, FL, Orlando
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
In reclutamentoFase 2
- Orlando VA Medical Center, Orlando, FL, Orlando
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
In reclutamento
- AdventHealth, Orlando
First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
In reclutamentoFase 1/2
- Research Site, Orlando
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
In reclutamentoFase 1
- Sarah Cannon Research Institute @ Florida Cancer, Orlando
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
In reclutamentoFase 1/2
- Research Site, Orlando
Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer
In reclutamentoFase 1
- AdventHealth Orlando, Orlando
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
In reclutamentoFase 1
- Florida Cancer Specialists & Research Institute, Orlando
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
In reclutamentoFase 1/2
- Research Site 137, Orlando
- Research Site 118, Celebration · a 17 mi di distanza
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Adventhealth, Orlando
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- Exelixis Clinical Site #8, Orlando
Exploring the Potential of Robotic Telesurgery in Remote Settings
In reclutamento
- AdventHealth, Celebration · a 17 mi di distanza
PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence
In reclutamentoFase 2
- AdventHealth, Orlando
Studi su Cancro alla prostata in altre città
- New York City, NY103 studi
- Houston, TX76 studi
- Los Angeles, CA61 studi
- Boston, MA59 studi
- St. Louis, MO46 studi
- Chicago, IL45 studi
- San Francisco, CA45 studi
- Philadelphia, PA44 studi
- Baltimore, MD43 studi
- Nashville, TN42 studi
- Seattle, WA42 studi
- Washington, DC38 studi
Altri studi a Orlando
- Cancro del polmone non a piccole cellule44 studi
- Obesità31 studi
- Cancro metastatico29 studi
- Sovrappeso27 studi
- Morbo di Alzheimer25 studi
- Diabete di tipo 224 studi
- Cancro (tutti i tipi)24 studi
- Cancro al seno23 studi
- Cancro ovarico22 studi
- Colite ulcerosa22 studi
- Cancro ai polmoni21 studi
- Cancro colorettale19 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.